Blueshift Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-513	Closed	-$246K	–	346
2023 Q1	$246K	Sell	513 -216	-30%	-$101K	0.1%	263
2022 Q4	$307K	Sell	729 -867	-54%	-$350K	0.14%	220
2022 Q3	$666K	Sell	1,596 -1,858	-54%	-$926K	0.14%	210
2022 Q2	$1.71M	Buy	3,454 +2,927	+555%	+$1.52M	0.28%	96
2022 Q1	$297K	Sell	527 -1,484	-74%	-$895K	0.03%	614
2021 Q4	$1.52M	Buy	+2,011	New	+$1.5M	0.13%	206
2021 Q3	–	Sell	-2,167	Closed	-$1.4M	–	1016
2021 Q2	$1.4M	Sell	2,167 -4,607	-68%	-$2.8M	0.08%	280
2021 Q1	$3.87M	Buy	+6,774	New	+$4.01M	0.4%	53
2020 Q4	–	Sell	-1,037	Closed	-$535K	–	698
2020 Q3	$535K	Buy	+1,037	New	+$525K	0.07%	332
2019 Q4	–	Sell	-1,775	Closed	-$591K	–	797
2019 Q3	$591K	Sell	1,775 -3,409	-66%	-$1.11M	0.09%	324
2019 Q2	$1.62M	Buy	5,184 +154	+3%	+$46.1K	0.21%	143
2019 Q1	$1.54M	Buy	5,030 +3,597	+251%	+$971K	0.22%	144
2018 Q4	$333K	Buy	+1,433	New	+$384K	0.06%	453